Description:
In this session, we’ll bring together insights from our fall CEO Forum + CPE and CFO Circles —highlighting what healthcare executives discussed during their in-person gatherings with peers. We’ll also share our perspective on the cross-cutting themes and their implications for industry organizations that partner with leading health systems.
Key Takeaways
Operating margins are stabilizing, but leaders remain cautious as policy volatility continues to cloud 2026 planning and capital decisions
Policy pressure from site-neutral payments, OB3, and 340B is forcing CEOs, CFOs, and CPEs to rethink service-line strategy—especially in oncology and rural care
AI is moving from experimentation to deployment, with executives focused on near-term ROI, governance, and freeing up clinical and financial capacity
Partnership models are shifting toward fewer, deeper relationships with clearer risk-sharing, faster implementation, and measurable financial impact
Executive priorities are diverging by role, making it more important than ever for industry partners to understand who they’re selling to—and why—inside the health system